Topic Hub
15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 15 of 15 clinical reviews.
A complete caregiver guide to administering tadalafil (Cialis) to adolescents ages 12 to 17, covering FDA-approved indications, dosing, timing, safety monitoring, and step-by-step administration instructions.
Read clinical reviewA physician-reviewed guide covering how tadalafil (Cialis) affects school performance, physical activity, and daily routines in adolescents aged 12 to 17, with dosing context, side-effect management, and activity restrictions.
Read clinical reviewA clinician-reviewed guide for caregivers helping older adults take tadalafil (Cialis) safely, covering dosing, drug interactions, fall risk, and when to call the prescriber.
Read clinical reviewA clinical review of tadalafil's effects on adolescent development, covering approved pediatric indications, hormonal interactions, bone and cardiovascular safety, and what parents and prescribers need to know.
Read clinical reviewA clinician-reviewed guide to tadalafil use in adolescents ages 12 to 17, covering FDA-approved indications, dosing, monitoring, and the critical transition to adult care for pulmonary arterial hypertension and other conditions.
Read clinical reviewA clinician-reviewed guide to how tadalafil (Cialis) affects older adults, covering pharmacokinetics, cardiovascular safety, dosing adjustments, and quality-of-life outcomes in men and women aged 65+.
Read clinical reviewA clinician-reviewed guide to tadalafil use in patients 65 and older, covering FDA-approved indications, off-label applications, age-related pharmacokinetics, drug interactions, and safety data from key clinical trials.
Read clinical reviewA clinician-reviewed guide to tadalafil use in geriatric patients aged 65+, covering physical activity safety, daily dosing, drug interactions, and practical lifestyle guidance backed by primary sources.
Read clinical reviewA clinician-reviewed guide to tadalafil use in adults aged 65 and older, covering dosing adjustments, drug interactions, cardiovascular safety, BPH management, and the transition from pediatric or adult urology care into geriatric-appropriate protocols.
Read clinical reviewComplete caregiver guidance on tadalafil (Cialis) use in pediatric patients under age 12, including approved indications, dosing, safety monitoring, and when to call the prescriber.
Read clinical reviewA clinical review of tadalafil use in pediatric patients under age 12, covering approved indications, developmental safety data, PDE5 mechanism in growing tissues, and what the evidence actually shows about growth, cardiovascular, and hormonal effects.
Read clinical reviewA clinical guide for parents and caregivers on how tadalafil affects daily school performance, physical activity, and safety monitoring in children under age 12, reviewed by the HealthRX medical team.
Read clinical reviewA clinician-reviewed guide to tadalafil use in pediatric patients under age 12, covering approved indications, dosing evidence, safety monitoring, and structured transition planning for adolescent and adult care handoff.
Read clinical reviewA clinician-reviewed guide to off-label tadalafil use in children under 12, covering pulmonary arterial hypertension, dosing data, trial evidence, safety signals, and how prescribers manage a drug with no FDA pediatric label for this age group.
Read clinical reviewA clinical review of tadalafil off-label prescribing in adolescents ages 12 to 17, covering approved vs. Unapproved indications, evidence from pediatric trials, dosing considerations, safety data, and regulatory context.
Read clinical review